These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16936425)

  • 1. Pharmacological cardioversion of persistent atrial fibrillation with and without a history of drug-resistant paroxysmal atrial fibrillation.
    Fujiki A; Sakamoto T; Iwamoto J; Nishida K; Nagasawa H; Mizumaki K; Inoue H
    Circ J; 2006 Sep; 70(9):1138-41. PubMed ID: 16936425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance of sinus rhythm and recovery of atrial mechanical function after cardioversion with bepridil or in combination with aprindine in long-lasting persistent atrial fibrillation.
    Fujiki A; Tsuneda T; Sakabe M; Nakagawa K; Mizumaki K; Hirai T; Inoue H
    Circ J; 2004 Sep; 68(9):834-9. PubMed ID: 15329504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced changes in fibrillation cycle length and organization index can predict chemical cardioversion of long-lasting atrial fibrillation with bepridil alone or in combination with aprindine.
    Fujiki A; Sakabe M; Nishida K; Sugao M; Tsuneda T; Iwamoto J; Mizumaki K; Inoue H
    Circ J; 2004 Dec; 68(12):1139-45. PubMed ID: 15564697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of bepridil in combination with Ic antiarrhythmic agent in converting persistent atrial fibrillation to sinus rhythm.
    Imai S; Saito F; Takase H; Enomoto M; Aoyama H; Yamaji S; Yokoyama K; Yagi H; Kushiro T; Hirayama A
    Circ J; 2008 May; 72(5):709-15. PubMed ID: 18441448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bepridil enhances aprindine-induced prolongation of atrial effective refractory period in a canine atrial rapid pacing model.
    Nakatani Y; Sakamoto T; Nishida K; Kataoka N; Yamaguchi Y; Sakabe M; Fujiki A; Mizumaki K; Inoue H
    J Cardiol; 2015 Nov; 66(5):445-50. PubMed ID: 26162947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of amiodarone versus bepridil in achieving conversion to sinus rhythm in patients with persistent atrial fibrillation: a randomised trial.
    Yamase M; Nakazato Y; Daida H
    Heart; 2012 Jul; 98(14):1067-71. PubMed ID: 22689712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological cardioversion of long-lasting atrial fibrillation.
    Fujiki A; Inoue H
    Circ J; 2007; 71 Suppl A():A69-74. PubMed ID: 17587743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between inflammation state and successful medical cardioversion using bepridil for refractory atrial fibrillation.
    Nishino M; Mori N; Nakamura D; Lee Y; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
    J Cardiol; 2013 Aug; 62(2):117-20. PubMed ID: 23623817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness and safety of bepridil in converting persistent atrial fibrillation to sinus rhythm.
    Fujiki A; Tsuneda T; Sugao M; Mizumaki K; Inoue H
    Am J Cardiol; 2003 Aug; 92(4):472-5. PubMed ID: 12914884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological cardioversion preceding left atrial ablation: bepridil predicts the clinical outcome following ablation in patients with persistent atrial fibrillation.
    Miyazaki S; Kuwahara T; Kobori A; Takahashi Y; Takei A; Sato A; Isobe M; Takahashi A
    Europace; 2009 Dec; 11(12):1620-3. PubMed ID: 19910313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of interleukin-6 and C-reactive protein levels to sinus maintenance after pharmacological cardioversion in persistent atrial fibrillation.
    Fujiki A; Sakamoto T; Nishida K; Mizumaki K; Inoue H
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):264-6. PubMed ID: 17878753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of postprocedural antiarrhythmic drug therapy with bepridil on maintaining sinus rhythm after catheter ablation for persistent atrial fibrillation.
    Kondo T; Miake J; Kato M; Ogura K; Iitsuka K; Yamamoto K
    J Cardiol; 2016 Sep; 68(3):229-35. PubMed ID: 26654806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy of renin angiotensin system inhibitors and bepridil is useful for maintaining sinus rhythm in patients with atrial fibrillation.
    Kawamura M; Ito H; Onuki T; Miyoshi F; Minoura Y; Asano T; Tanno K; Kobayashi Y
    J Cardiol; 2007 Dec; 50(6):343-50. PubMed ID: 18186308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion and maintenance of sinus rhythm by bepridil in patients with persistent atrial fibrillation.
    Nakazato Y; Yasuda M; Sasaki A; Iida Y; Kawano Y; Nakazato K; Tokano T; Mineda Y; Sumiyoshi M; Nakata Y; Daida H
    Circ J; 2005 Jan; 69(1):44-8. PubMed ID: 15635201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of the additional bepridil treatment in patients with atrial fibrillation refractory to class I antiarrhythmic drugs.
    Miyaji K; Tada H; Fukushima Kusano K; Hashimoto T; Kaseno K; Hiramatsu S; Tadokoro K; Naito S; Nakamura K; Oshima S; Taniguchi K; Ohe T
    Circ J; 2007 Aug; 71(8):1250-7. PubMed ID: 17652890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
    Frick M; Darpö B; Ostergren J; Rosenqvist M
    Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial antiarrhythmic therapy: role of amiodarone in prevention of atrial fibrillation recurrence--a lesson from the HOT CAFE Polish Study.
    Kosior DA; Opolski G; Wozakowska-Kaplon B; Rabczenko D;
    Cardiology; 2005; 104(1):35-44. PubMed ID: 15942183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repetitive evaluation of fibrillation cycle length predicts the efficacy of bepridil for interruption of long-lasting persistent atrial fibrillation.
    Aoyama Y; Niwano S; Niwano H; Satoh A; Kishihara J; Ishikawa S; Murakami M; Fukumoto K; Ueno K; Izumi T
    Int Heart J; 2011; 52(6):353-8. PubMed ID: 22188708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence of atrial fibrillation after internal cardioversion of persistent atrial fibrillation: prognostic importance of electrophysiologic parameters.
    Okumura Y; Watanabe I; Nakai T; Sugimura H; Hashimoto K; Masaki R; Ohkubo K; Takagi Y; Shindo A; Ozawa Y; Saito S; Kanmatsuse K
    Circ J; 2005 Dec; 69(12):1514-20. PubMed ID: 16308501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the efficacy of antiarrhythmic agents for interrupting persistent atrial fibrillation according to spectral analysis of the fibrillation waves on the surface ECG.
    Niwano S; Sasaki T; Kurokawa S; Kiryu M; Fukaya H; Hatakeyama Y; Niwano H; Fujiki A; Izumi T
    Circ J; 2009 Jul; 73(7):1210-8. PubMed ID: 19436116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.